Articles

Beverages sweetened with fructose or high-fructose corn syrup can worsen cardiovascular risk factors, even in the young and healthy, researchers have found.…

Optimum screening cut-offs for HbA1c in emergency setting similar to outpatient care….

The need to establish diabetes management programs that are more accessible to the elderly is gaining greater urgency amid unprecedented growth of older minority populations who are most at risk, particularly older African-Americans, according to a new report.…

Children with Type 1 diabetes may achieve better blood-sugar control if their parents are more authoritative with them, a new study has found….

A new study finds that people who chew their food more take in fewer calories, which may help them control their weight. 

Americans downed nearly a quarter less added sugar in 2008 than they did nine years earlier, a new report concludes.…

Patients with diabetes who also suffer from depression are more likely to develop a serious complication known as diabetic retinopathy, a disease that damages the eye’s retina, and causes blindness, a five-year study finds….

With this special bonus edition of our highly successful GLP-1 special series, we provide you with an easy list so you can find all of our analyses in one place…. Just click on these links to access each analysis. GLP-1 Knowledge Survey Part I GLP-1 Knowledge Survey Part II GLP-1 …

Bydureon could be available by Feb or March of 2012 or even sooner. Because Bydureon is the same drug as Byetta (which has been in the market for over 5 years and basically is the same drug) except that Bydureon only needs to be injected once a week instead of …

Takeda announced today that it resubmitted two NDA’s to the FDA for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.…